SearcharxivSearch

arXiv subjects

Salil B Patel

Publications and source records attributed to Salil B Patel.

2 recordsLinked to original sources

2D and 3D Deep Learning Models for MRI-based Parkinson's Disease Classification: A Comparative Analysis of Convolutional Kolmogorov-Arnold Networks, Convolutional Neural Networks, and Graph Convolutional Networks

Parkinson's Disease (PD) diagnosis remains challenging. This study applies Convolutional Kolmogorov-Arnold Networks (ConvKANs), integrating learnable spline-based activation functions into convolutional layers, for PD classification using structural MRI. The first 3D implementation of ConvKANs for medical imaging is presented, comparing their performance to Convolutional Neural Networks (CNNs) and Graph Convolutional Networks (GCNs) across three open-source datasets. Isolated analyses assessed performance within individual datasets, using cross-validation techniques. Holdout analyses evaluated cross-dataset generalizability by training models on two datasets and testing on the third, mirroring real-world clinical scenarios. In isolated analyses, 2D ConvKANs achieved the highest AUC of 0.99 (95% CI: 0.98-0.99) on the PPMI dataset, outperforming 2D CNNs (AUC: 0.97, p = 0.0092). 3D models showed promise, with 3D CNN and 3D ConvKAN reaching an AUC of 0.85 on PPMI. In holdout analyses, 3D ConvKAN demonstrated superior generalization, achieving an AUC of 0.85 on early-stage PD data. GCNs underperformed in 2D but improved in 3D implementations. These findings highlight ConvKANs' potential for PD detection, emphasize the importance of 3D analysis in capturing subtle brain changes, and underscore cross-dataset generalization challenges. This study advances AI-assisted PD diagnosis using structural MRI and emphasizes the need for larger-scale validation.

eess.IV

Hierarchical Machine Learning Classification of Parkinsonian Disorders using Saccadic Eye Movements: A Development and Validation Study

Discriminating between Parkinson's Disease (PD) and Progressive Supranuclear Palsy (PSP) is difficult due to overlapping symptoms, especially early on. Saccades (rapid conjugate eye movements between fixation points) are affected by both diseases but conventional saccade analyses exhibit group level differences only. We hypothesized analyzing entire saccade raw time series waveforms would permit superior individual level discrimination between PD, PSP, and healthy controls (HC). 13,309 saccadic eye movements from 127 participants were analyzed using a novel, calibration-free waveform analysis and hierarchical machine learning framework. Individual saccades were classified based on which trained model could reconstruct each waveform with minimum error, indicating the most likely condition. A hierarchical classifier then predicted overall status (recently diagnosed and medication-naive 'de novo' PD, 'established' PD on antiparkinsonian medication, PSP, and healthy controls) by combining each participant's saccade results. This approach substantially outperformed conventional metrics, achieving high AUROCs distinguishing de novo PD from PSP (0.92-0.97), de novo PD from HC (0.72-0.89), and PSP from HC (0.90-0.95), while the conventional model showed limited performance (AUROC range: 0.45-0.75). This calibration-free waveform analysis sets a new standard for precise saccadic classification of PD, PSP, and HC, increasing potential for clinical adoption, remote monitoring, and screening.

q-bio.QM